Omega Therapeutics, Inc. ( OMGA) - Key Metrics
Stock symbol OMGA is outdated, potentially delisted? Maybe it is available on other exchange?
OMGA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.04 | -$0.30 | -$0.23 | -$0.24 |
| 2024Q1 | $0.04 | -$0.36 | -$0.21 | -$0.22 |
| 2023Q4 | $0.02 | -$0.37 | -$0.31 | -$0.33 |
| 2023Q3 | $0.02 | -$0.40 | -$0.42 | -$0.43 |
| 2023Q2 | $0.01 | -$0.54 | -$0.42 | -$0.44 |
OMGA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -1.90 |
| 2024Q1 | ? | -2.19 |
| 2023Q4 | ? | -2.05 |
| 2023Q3 | ? | -1.33 |
| 2023Q2 | ? | -2.60 |
OMGA
Price: $0.14
52 week price:
Earnings Per Share: -1.32 USD
P/E Ratio: -0.14
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.4 million